Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bosse

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Science Translational Medicine|November 19, 2025
Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastomaAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung CancerAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Journal for Immunotherapy of Cancer|September 27, 2022
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumorsJessica B Foster, Crystal Griffin, Jo Lynne Rokita, et al.
Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Cancer Discovery|September 15, 2022
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk NeuroblastomaKristopher R Bosse, Anna Maria Giudice, Maria V Lane, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Cancer Research|February 22, 2012
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicityKristopher R Bosse, Sharon J Diskin, Kristina A Cole, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Science Translational Medicine|November 19, 2025
Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastomaAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung CancerAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Journal for Immunotherapy of Cancer|September 27, 2022
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumorsJessica B Foster, Crystal Griffin, Jo Lynne Rokita, et al.
Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Cancer Discovery|September 15, 2022
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk NeuroblastomaKristopher R Bosse, Anna Maria Giudice, Maria V Lane, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Cancer Research|February 22, 2012
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicityKristopher R Bosse, Sharon J Diskin, Kristina A Cole, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Pageof 6